|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
24,911,000 |
Market
Cap: |
4.10(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$96 - $180.42 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Krystal Biotech is a clinical-stage biotechnology company focused on the development of gene therapies to improve the lives of patients living with rare diseases. Co. has developed a gene delivery platform that enables off-the-shelf treatments for serious dermatology and respiratory diseases. Co.'s platform consists of a patented, engineered viral vector derived from the herpes simplex virus type 1 (HSV-1) that it has optimized for local and repeat gene transfer to epithelial cells. Co.'s main product candidate is Beremagene geperpavec (B-VEC), which is for the treatment of dystrophic epidermolysis bullosa, a rare skin disease caused by missing or mutated mutated type VII collagen protein.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
120,000 |
243,087 |
374,522 |
1,074,015 |
Total Sell Value |
$20,378,128 |
$34,451,688 |
$51,220,906 |
$115,575,756 |
Total People Sold |
3 |
4 |
6 |
7 |
Total Sell Transactions |
5 |
13 |
19 |
68 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Krishnan Suma |
Chief Operating Officer |
|
2018-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
16,213 |
1,951,462 |
|
- |
|
Riley Anthony A |
Chief Financial Officer |
|
2018-05-22 |
4 |
B |
$10.75 |
$30,100 |
D/D |
2,800 |
2,800 |
2.74 |
- |
|
Norby R Douglas |
Director |
|
2018-05-09 |
4 |
B |
$10.42 |
$93,780 |
D/D |
9,000 |
9,000 |
2.39 |
- |
|
Krishnan Krish S |
President and CEO |
|
2018-03-19 |
4 |
B |
$11.00 |
$550,000 |
D/D |
50,000 |
1,985,249 |
3.23 |
- |
|
Rossi Dino A |
Director |
|
2017-09-22 |
4 |
A |
$0.00 |
$0 |
D/D |
123,691 |
123,691 |
|
- |
|
Janney Daniel |
Director |
|
2017-09-22 |
4 |
A |
$0.00 |
$0 |
I/I |
124,456 |
455,046 |
|
- |
|
Janney Daniel |
Director |
|
2017-09-22 |
4 |
B |
$10.00 |
$2,000,000 |
I/I |
200,000 |
330,590 |
2.1 |
- |
|
Krishnan Suma |
Chief Operating Officer |
|
2017-09-22 |
4 |
A |
$0.00 |
$0 |
I/I |
112,162 |
112,162 |
|
- |
|
Krishnan Suma |
Chief Operating Officer |
|
2017-09-22 |
4 |
B |
$10.00 |
$1,000,000 |
D/D |
100,000 |
1,935,249 |
3.23 |
- |
|
Krishnan Krish S |
President and CEO |
|
2017-09-22 |
4 |
A |
$0.00 |
$0 |
I/I |
112,162 |
112,162 |
|
- |
|
Krishnan Krish S |
President and CEO |
|
2017-09-22 |
4 |
B |
$10.00 |
$1,000,000 |
D/D |
100,000 |
1,935,249 |
3.23 |
- |
|
136 Records found
|
|
Page 6 of 6 |
|
|